Please do not leave this page until complete. This can take a few moments.
After voters rejected a ballot question last November that would have legalized some psychedelics, a number of newly filed bills have reignited the conversation and will lead another attempt to move toward decriminalizing psilocybin.
The bills don't directly mirror the failed ballot measure — which opponents contended was too wide-reaching — and instead represent smaller, more measured steps to introduce legalization across the state and regulate usage for Bay Staters with various medical and mental health conditions.
Northampton Rep. Lindsay Sabadosa offered a bill (HD 4017) that would introduce a statewide, five-site pilot program in which non-profit centers would offer psilocybin treatment for mental and physical health needs under the administration of mental health and medical professionals.
Sabadosa called the approach "more pragmatic" than the failed measure. Based on feedback and concerns from constituents and voters on either side of the measure, Sabadosa said the idea of utilizing psychedelics in a regulated manner, and for various conditions, isn't what voters opposed — the wording of the individual measure was. She looked to other states where such substances are legal, and found site-monitoring and data-collection to be essential pieces when writing the legislation, she said.
Cambridge Rep. Steve Owens — whose bill (HD 3368) would remove certain criminal penalties related to psilocybin that hasn't been medically prescribed — also described receiving extensive feedback. "Over the course of the Question 4 campaign, constituents reached out to me to say that this kind of treatment saved their life," he wrote to MASSterList. "I think we owe it to them to at least continue the conversation."
Fellow Cambridge Rep. Marjorie Decker filed a bill (HD 4196) that proposes a pilot "Psilocybin-Assisted Therapy Program," enabling the research and development of psilocybin services for adults struggling with conditions like PTSD, end-of-life stress and depression. Scituate Rep. Patrick Kearney filed another bill (HD 1003) that would establish a framework of "regulated adult use, support services, and cultivation of psilocybin-containing fungi."
As Beacon Hill tests the psychedelic waters, remember there are glimmers of support within the Massachusetts congressional delegation: U.S. Sen. Elizabeth Warren voiced support last year, and U.S. Rep. Seth Moulton backed legalization as a tool to support veterans' mental health.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments